Top 10 Life Science Angel Investors in France in April 2025
A list of 10 angel investors that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.Top 10 Life Science Angel Investors in France in April 2025
Investor | Life Science France investments |
---|---|
Sylvain Zimmer | 2 |
Fidji Simo | 1 |
Bertrand Jacquelot | 1 |
Sebastian Lombardo | 1 |
Jacques Lewiner | 1 |
Andrew Nutter | 1 |
Xavier Niel | 1 |
Bernard Majoie | 1 |
Christophe Ricard | 1 |
Irwan Bello | 1 |
Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.
Show more
Investment focus
- Software, Financial Services, SaaS
- Seed, Pre-Seed, Angel
- France, United States, United Kingdom
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
- TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Series A, Series B
- United States, United Kingdom, France
Portfolio highlights
- Polywork — Launch an AI-powered personal website to showcase your work, grow your personal brand, or start your side hustle.
- Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.
- Archy — SaaS Practice Management Software for Dental Practices
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more
Investment focus
- E-Commerce, Information Technology, Food and Beverage
- Pre-Seed, Seed, Angel
- France, United States
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Sebastian Lombardo - CEO @ Valtech
Show more
Investment focus
- Apps, Internet, Lifestyle
- Seed
- France, United States
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Series C
- France
Portfolio highlights
- Cytoo — CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening.They develop, manufacture, and distribute products that make cellular analysis robust and reliable by dramatically decreasing cell variability.There new micropattern-based products aredesigned to meet the needs of all clients whatever their research goals. They are open to suggestions or specific requests that can improve and spread the scope of this breakthrough in quantitative cell analysis.
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Pre-Seed, Funding Round
- France, United Kingdom, United States
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Series A, Funding Round
- France, United States, United Kingdom
Portfolio highlights
- Cube — Cube AI boosts back-office logistics efficiency, allowing teams to handle more loads and focus on human relationships.
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- The Mobile-First Company — Early Stage Startup that is Simplifying Business, One App at a Time. Forget about those overcomplicated, pricey software giants. We're building easy, mobile-first tools that actually make sense.
Bernard Majoie - President @ Fournier-Majoie
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Christophe Ricard CEO of OM Pharma
Show more
Investment focus
- Life Science, Biotechnology, Medical Device
- Seed, Series B
- France
Portfolio highlights
- Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.
Irwan Bello is an individual investor.
Show more
Investment focus
- Information Technology, Internet, Life Science
- Seed, Pre-Seed
- France, United States
Portfolio highlights
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
- Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
- Twin — Agentic AI, made actionable.
Investors by industry
Proptech
Impact
Hardware
Gaming
Google
Consumer
Energy
Climate
Marketplace
FinTech
Health Care
Community
Artificial intelligence
Biotech
EdTech
Sustainability
Venture Capital
Organic Food
Real Estate
Web3
Big Data
Education
Finance
Video Games
Payments
Publishing
Food and Beverage
Financial Services
Retail
Clean Energy
B2B
Social Media
Android
Art
Digital Media
Social Network
Franchise
Photography
Construction
Local
eSports
Legal
Enterprise Software
Internet
Infrastructure
Sports
Medical
Email
Wellness
Music
Manufacturing
Mobile
Platforms
Mobile Advertising
Recruiting
Biotechnology
Hospitality
Cannabis
Fitness
Travel
Beauty
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Theatre
Film
Life Science
SaaS
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Facebook
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
Germany
United Kingdom
India
New Zealand
Canada
Ireland
Australia
United States
South Korea
China
Oceania
Japan
Sri Lanka
Singapore
Europe
Indonesia
Georgia
Ecuador
Bahrain
Faroe Islands
Belize
Egypt
Croatia
Greece
Ghana
Hungary
Finland
Estonia
Costa Rica
Czech Republic
Ethiopia
France
Belgium
Hong Kong
Barbados
Gibraltar
Bermuda
Belarus
Algeria
Chile
Denmark
Bulgaria
Liberia
Kuwait
Peru
Myanmar
Liechtenstein
Morocco
Norway
Mexico
Panama
Lithuania
Nicaragua
Mali
Lebanon
Mauritius
Philippines
Israel
Jersey
Malaysia
Malta
Italy
Tajikistan
Togo
Seychelles
Poland
Zimbabwe
Tanzania
Puerto Rico
Serbia
Sweden
Senegal
Taiwan
Rwanda
Tunisia
Zambia
Slovenia
Sierra Leone
San Marino
Thailand
Uruguay
Portugal
Uzbekistan
Russian Federation
Turkey
El Salvador
Ukraine
Uganda
Venezuela
Dominican Republic
Namibia
Iceland
Azerbaijan
Nigeria
Bahamas
Iraq
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Pakistan
Albania
Romania
Grenada
Bangladesh
Argentina
Jordan
South Africa
Vietnam
LATAM
Spain
Armenia
Brazil
Africa
Middle East
Qatar
Asia
Saudi Arabia
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Cyprus
Oman
Latvia
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
Angel Investors in France by industry
Crowdfunding
Venture Capital
Fitness
Restaurants
Cryptocurrency
Finance
Video Games
Wine And Spirits
Organic Food
Photography
Education
Wellness
Medical Device
Email
Social Media
Internet
Social Network
Art
Manufacturing
Digital Media
Android
Blockchain
Mobile
Legal
Construction
Software
Sports
Enterprise Software
Music
Travel
Hospitality
Recruiting
InsurTech
Biotechnology
FinTech
Consumer
Enterprise
Health Care
Energy
EdTech
Sustainability
Proptech
SaaS
Marketplace
Community
Hardware
Retail
Mobile Apps
Infrastructure
Fashion
Beauty
B2B
Web3
Impact
Payments
Financial Services
Food and Beverage
Artificial intelligence
Real Estate
Publishing
Big Data
Gaming
Media (entertainment)
Platforms
Medical
Life Science
Transportation
Agriculture (agtech)
Renewable Energy
Automotive
Machine Learning
Biotech
Climate